University of Texas M.D. Anderson Cancer Centers Proton Therapy Center.


January 13, 2010 – There is growing awareness about the advantages of proton therapy compared to conventional photon radiation therapy, especially when treating pediatric patients. Protons release most of their energy when they hit the tumor and deliver no exit dose beyond the tumor boundary, unlike photons. This enables the dose to better conform to the tumor and minimizes damage to healthy surrounding tissue, and enabling the radiation oncologist can potentially deliver an even greater dose. This less damaging deliver of dos is especially important when treating children by reducing radiation to growing and developing tissues.

As the proton therapy becomes more prevalent, the first proton-certified radiation therapists (RTTs) in the U.S. received advanced proton therapy certificates was notable. The RTTs earned their certificates at the Ivy Tech Community College-Bloomington program, which provides 16 college credits or the equivalent of two years of continuing education (CE) credits from the American Registry of Radiologic Technologists (ARRT). A portion of the program was held at the ProCure Training and Development Center in Bloomington, a training facility dedicated to proton therapy.

More specialized training in the field will be needed as more proton therapy spring up. Procure, a proton therapy center development company, is currently building a network of proton therapy treatment facilities across the United States. Construction is under way on a ProCure facility in suburban Chicago. Additional centers are in development in suburban Detroit, Mich., South Florida, Seattle, Wash., and Somerset, N.J.

For more information: www.ivytech.edu/bloomington and www.procure.com


Related Content

News | Radiation Dose Management

April 25, 2024 — BIOTRONIK, a leading global medical technology company specializing in innovative cardiovascular and ...

Time April 25, 2024
arrow
News | Artificial Intelligence

March 28, 2024 — As artificial intelligence (AI) makes its way into cancer care – and into discussions between ...

Time March 28, 2024
arrow
News | Prostate Cancer

March 27, 2024 — A minimally invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation ...

Time March 27, 2024
arrow
Videos | Radiation Oncology

In the conclusion of this 3-part video series on recent advancements in diagnostic radiology, current editorial advisory ...

Time March 19, 2024
arrow
News | Breast Imaging

March 18, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time March 18, 2024
arrow
Feature | Radiation Oncology | By Christine Book

Appreciating the considerable advances in the clinical application of artificial intelligence (AI) within healthcare ...

Time March 06, 2024
arrow
News | FDA

March 1, 2024 — Varian, a Siemens Healthineers company, announced that it has received 510(k) clearance from the U.S ...

Time March 01, 2024
arrow
News | Breast Imaging

February 22, 2024 — The FAST-Forward randomized trial from the UK found that ultrahypofractionated whole breast ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 22, 2024 — The National Institutes of Health has launched a clinical trials network to evaluate emerging ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 14, 2024 — Accuray Incorporated announced that the team at Quebec’s Montérégie Integrated Cancer Center, part ...

Time February 14, 2024
arrow
Subscribe Now